Search research articles
Contact Us
Filters
Showing results (171-180 of 278) with videos related to
Page
of 28
Sort By:
The New Microbiologica
|
April 1, 1994
Prevalence of viral antibodies in gingival crevicular fluid
N Hochman, E Mizrachi, J Ehrlich, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 12, 2010
The rational design of a novel potent analogue of the 5'-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity
Fouzia Machrouhi, Nouara Ouhamou, Keith Laderoute, et al.
Journal of Paediatrics and Child Health
|
May 6, 1998
Malnutrition, gastroenteritis and trypsinogen concentration in hospitalised Aboriginal children
G L Briars, S J Thornton, Y Forrest, et al.
Pacing and Clinical Electrophysiology : PACE
|
April 8, 1999
The utility of quantitative body surface isoarea mapping for predicting ventricular tachyarrhythmias
B G Goldner, L Horwitz, N Kohn, et al.
Monatsschrift Fur Kinderheilkunde
|
May 1, 1980
[Progressive rubella panencephalitis in a child with acute lymphatic leukemia]
E Meyer, P H Weiss-Wichert, J Ehrlich, et al.
Public Health Action
|
December 27, 2021
Integration of TB into child health policies in Africa's high-burden countries: a normative analysis
J Ehrlich, A L Garcia-Basteiro, A Brands, et al.
Molecular Cancer Therapeutics
|
October 5, 2022
Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models
Didier Scherrer, Noel Barrett, Luc Teyton, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)
|
February 19, 2014
Azaserine: microbiological studies
G L COFFEY, A B HILLEGAS, M P KNUDSEN, et al.
Blood
|
July 15, 1991
The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance
J Keijer, M Linders, A J van Zonneveld, et al.
Frontiers in Veterinary Science
|
September 19, 2025
Tocilizumab binds to canine IL-6 receptor and elicits <i>in-vitro</i> inhibitory biological response
Yael Merbl, Jesus M Lopez Baltazar, Michael Byron, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 278) with videos related to
Sort By:
Page
of 28
The New Microbiologica
|
April 1, 1994
Prevalence of viral antibodies in gingival crevicular fluid
N Hochman, E Mizrachi, J Ehrlich, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 12, 2010
The rational design of a novel potent analogue of the 5'-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity
Fouzia Machrouhi, Nouara Ouhamou, Keith Laderoute, et al.
Journal of Paediatrics and Child Health
|
May 6, 1998
Malnutrition, gastroenteritis and trypsinogen concentration in hospitalised Aboriginal children
G L Briars, S J Thornton, Y Forrest, et al.
Pacing and Clinical Electrophysiology : PACE
|
April 8, 1999
The utility of quantitative body surface isoarea mapping for predicting ventricular tachyarrhythmias
B G Goldner, L Horwitz, N Kohn, et al.
Monatsschrift Fur Kinderheilkunde
|
May 1, 1980
[Progressive rubella panencephalitis in a child with acute lymphatic leukemia]
E Meyer, P H Weiss-Wichert, J Ehrlich, et al.
Public Health Action
|
December 27, 2021
Integration of TB into child health policies in Africa's high-burden countries: a normative analysis
J Ehrlich, A L Garcia-Basteiro, A Brands, et al.
Molecular Cancer Therapeutics
|
October 5, 2022
Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models
Didier Scherrer, Noel Barrett, Luc Teyton, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)
|
February 19, 2014
Azaserine: microbiological studies
G L COFFEY, A B HILLEGAS, M P KNUDSEN, et al.
Blood
|
July 15, 1991
The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance
J Keijer, M Linders, A J van Zonneveld, et al.
Frontiers in Veterinary Science
|
September 19, 2025
Tocilizumab binds to canine IL-6 receptor and elicits <i>in-vitro</i> inhibitory biological response
Yael Merbl, Jesus M Lopez Baltazar, Michael Byron, et al.
Page
of 28